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cholesterol stigmasterol ergosterol
Sterols found in plants (e.g. stigmasterol) and fungi (e.g. ergosterol) are structurally similar to cholesterol but have an 
extra methyl or ethyl on C-24 of the side chain. Because of their structural similarity to cholesterol, these phytosterols can 
lower low-density lipoprotein (LDL) cholesterol levels by displacing cholesterol from intestinal micelles.1 Thus, foods 
containing phytosterols are thought to have important health benefits. Mushrooms, in particular, have attracted attention for
this and are also a rich, natural food source of vitamin D2. Vitamin D is critical to bone health and has received increased 
notice for its role in immune function and prevention of some types of cancer and various diseases.2–5 Vitamin D2 in 
mushrooms is produced by exposure to sunlight and other sources of UV light, a direct consequence of their ergosterol 
content.6 Therefore, commercially produced mushrooms are sometimes UV treated to increase Vitamin D2 levels.
Ergosterol Vitamin D2
Other mushroom sterols, for example ergosta-5,7-dienol, have recently been shown to undergo photolytic reactions to 
form previously unrecognized forms of vitamin D (vitamin D4).7,8 These D vitamins may turn out to be useful pharmaceutical 
agents, illustrating the need for more complete knowledge of mushroom sterol profiles.9
This research project looked at morel mushrooms (Morchella esculenta), which are both highly valued for their delicious 
flavor and very high vitamin D2 content.7 Morels are also interesting because they contain high amounts of brassicasterol and 
campesterol and relatively little of the usual dominant ergosterol.7
brassicasterol campesterol
GC-MS analysis of TMS-derivatized sterols from dried morels in our lab verified the presence of ergosterol, 
brassicasterol, and campesterol. More significantly, our work identified several previously unknown sterols in morels 
including 24-methylenecholesterol and ergosta-7,24(28)-dienol (episterol) based on matching the mass spectra to literature 
spectra. However, an unidentified compound with a M+ at m/z = 468, indicating a trienol, was also detected. The mass 
spectrum also showed peaks at m/z = 129 (TMSOC3H4+), indicating a double bond at C-5, and 123 (C9H15+), 343 (M – C9H15, 
-H2), and 372 (M – C7H12) indicating a di-unsaturated side chain (Fig. 1). Thus, this unknown compound has been proposed to 
be ergosta-5,22,24(28)-trienol (1). An intriguing possibility is that an uncommon biosynthesis pathway to brassicasterol, 
which proceeds through 1 instead of the normal intermediate, campesterol, occurs in morels.
Unfortunately, 1 is a rare compound and the mass spectrum of its TMS ether has not been published. Therefore, the purpose of 
this research was to synthesize 1 to prove the identity of the unknown compound. We envisioned the synthesis of 1 beginning 
with stigmasterol, which is converted in four steps using a literature method12,13 to 5. Sequential Julia and Wittig reactions 
followed by hydrolysis of the acetate ester would then afford compound 1 (Scheme 2).
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Scheme 2: Synthesis of Ergosta-5,22,24(28)-trienol
Scheme 1: Synthesis of Modified Julia Reagent 
Background
Figure 1: Mass Spectrum of Unknown Sterol TMS Ether in Morels  
Procedure
1-Bromo-3-methyl-2-butanone (9)10
To a 0-5 °C solution of 3-methyl-2-butanone (15 g, 174 mmol) in methanol (105 mL), bromine (28 g, 174 mmol) was added, 
forming a dark red color. The solution was stirred for 1.5 h during which the reaction temp was allowed to reach 20 °C. Once 
the red color faded, water (52 mL) was added and the solution was stirred at room temp overnight. Water (160 mL) was added 
and the solution washed with DCM (4 x 85 mL). The organic layers were combined and washed with aq 10% potassium 
carbonate (35 mL) and water (2 x 35 mL), then dried over anhydrous Na2SO4. The solvent was removed in vacuo, yielding the 
crude product (29.31 g, 102%), which was distilled under reduced pressure to give a light brown liquid product (16.03 g, 56%). 
The 1H NMR showed the desired 9 along with the 3-bromo isomeric product in a 91:9 ratio. 1H NMR (CDCl3) 3.98 (s, 2H), 
2.99-2.92 (m, 1H), 1.15 (d, J= 6.9 Hz, 6H), APCI-MS, m/z = 164.9, 166.9 (M + H).
1-Benzo[d]thiazol-2-ylthio)-3-methylbutan-2-one (10)11
A suspension of 2-mercaptobenzothiazole (7.31 g, 44 mmol) and t-BuOK (5.40 g, 48 mmol) in THF (60 mL) was refluxed for 
30 min. Over 10 min, 9 (8 g, 48 mmol) was added dropwise. The solution was refluxed for 5 h, then cooled to room temp. After 
water (45 mL) was added, the solution was extracted using DCM (3 x 45 mL) then dried over anhydrous Na2SO4. The solvent 
was removed in vacuo to give the crude product (11.28 g, 93%). The crude (5 g) was purified by silica column chromatography 
(ethyl acetate: hexane = 1:3) to give a 10 as a light brown solid (3.84 g, 72%): mp 37-41°C; 1H NMR (CDCl3) 7.88 (d, J= 8.3 
Hz, 1H), 7.73 (d, J= 8.3 Hz, 1H), 7.42 (t, J= 16.5 Hz, 1H), 7.30 (t, J= 16.2, 1H). 4.45 (s, 2H), 3.0-2.9 (m, 1H), 1.21 (d, J= 6.9, 
6H); EI-MS, m/z = 219, 176, 149, 121, 108, 71, 63. APCI-MS, m/z = 252.1 (M + H).
1-Benzo[d]thiazol-2-ylsulfonyl)-3-methyl-2-butanone (11)11
To a solution of 10 (1.136 g, 4.5 mmol) in THF (7 mL) was added m-CPBA (1.93 g, 11 mmol) in DCM (12 mL) dropwise at 
room temp. After the reaction was complete, as detected by TLC, sodium bicarbonate (10 mL) was added. The mixture was 
extracted with ethyl acetate (3 x 25 mL), dried over anhydrous Na2SO4, and the solvent removed in vacuo to give the crude 
product (1.5 g, 117%), which was recrystallized (methanol) to afford 11 as a crystalline white solid (0.25 g, 19.5%): mp 104-
108°C; IR 2972, 2921, 2875, 2360, 1718 cm-1; 1H NMR (CDCl3) 8.15 (d, J= 7.9 Hz, 1H), 7.98 (d, J= 7.6 Hz, 1 H), 7.60-7.53 
(m, 2H), 4.63 (s, 2H), 2.87-2.82 (m, 1H), 1.11 (d, J= 6.9 Hz, 6H); EI-MS, m/z = 219, 177, 162, 148, 136, 109, 69, 63, 43; APCI-
MS, m/z = 283.70 (M + H).
Stigmasterol acetate (3)12
Acetic anhydride (36 mL, 0.39 mol) was added to a stirred solution of 2 (2.5 g, 6 mmol) in absolute pyridine (72 mL) 
containing catalytic amounts of DMAP. The resulting solution was stirred at room temp for 0.5 h then treated with NaHCO3(sat) 
at 0 °C. The solution was extracted with ethyl acetate (3 x 50 mL) and the organic layers were combined, washed with water (60 
mL), dried over Na2SO4, filtered, and concentrated in vacuo to give crude 3 with significant contamination by pyridine as 
determined by 1H NMR. Thus, the crude was dissolved in ethyl acetate (150 mL) and washed with HCl (0.5 M) and water twice 
more. After drying and removal of the solvent, 3 was obtained as a pale yellow solid (0.52 g, 19%): 1H NMR (CDCl3) 5.15 (dd, 
J= 15.1, 8.3 Hz, 1H), 5.01 (dd, J= 15.0, 8.4 Hz, 1H) 4.65-4.53 (m, 1H) 2.31 (d, J= 7.6 Hz, 2H), 2.03 (s, 3H). 
α and β Epoxides of stigmasterol acetate (4)13
To a 0 °C solution of 3 (0.52 g, 1.1 mmol) in DCM (35 mL) was added m-CPBA (0.23 g, 1.3 mmol). After 4 h at 0°C, the 
reaction was diluted with satd. aq. K2CO3 (135 mL) and extracted with DCM (3 x 100 mL). The combined organic layers were 
dry over anhydrous Na2SO4 and concentrated in vacuo to give a 3:1 mixture of diastereomers (0.56 g, 104%): 1H NMR (CDCl3) 
5.10 (dd, J= 15.3, 8.4 Hz, 1H), 5.03-4.70 (m, H) 3.07 (d, J= 2.1 Hz, 0.33H), 2.88 (d, J = 4.1 Hz, 0.68H), 2.03 (s, 3H).
Pregnane-20α-carboxaldehyde-5,6-epoxy-3-yl acetate (5)13
A -78 °C solution of 4 (0.35 g, 0.74 mmol) in 1:1 DCM/MeOH (12 mL) was treated with a gaseous stream of ozone (1 g/h) 
from an A2Z Ozone MP 1000 110V Multi-Purpose Ozone Generator for 1.5 h. The solution was purged with oxygen (5 min). 
Triethylamine (0.21 mL, 1.5 mmol) was added and stirred for several days at room temp. The solution was extracted with DCM 
(50 mL), washed with HCl (3 x 30 mL) and water (30 mL) then dried over Na2SO4 and concentrated in vacuo to afford a sticky, 
clear substance (0.21 g, 72%): 1H NMR (CDCl3) 9.61 (d, J= 3.44 Hz, 0.26H), 9.54 (d, J= 3.44 Hz, 0.12H), 5.01-4.70 (m, 1H), 
3.08 (d, 0.27H), 2.89 (d, J= 4.5 Hz, 0.73H).
Results Discussion
Synthesis of the modified Julia reagent commenced with the bromination of 3-methyl-
2-butanone using molecular bromine (Scheme 1). The desired 9 was obtained with good 
yield (102%). However, the isomer 3-bromo-3-methyl-2-butanone (9%) was observed in the 
1H NMR spectrum. Distillation to remove the minor isomer was unsuccessful but lowered 
our yield (56%). The bromoketone mixture was reacted with 2-mercaptobenzothiazole and 
t-BuOK in THF to afford 10 with a good crude yield (93%). Purification using silica column 
chromatography (ethyl acetate:hexane = 1:3) gave a pure product (72%) as determined by
1H NMR. Oxidation with mCPBA gave the desired sulfone, 11, in a crude yield of 117%. 
Recrystallization afforded a white powder (17%) with good purity according to 1H NMR. 
GC-MS analysis also showed good purity but was puzzling because it showed an apparent 
M+ at m/z = 219. Rather than M+, this corresponds to a loss of SO2 (64 g/mol) from the 
molecular ion (m/z = 283) indicating an intriguing rearrangement of the product in the mass
spectrometer. APCI mass spectrometry confirmed the molecular weight as 283 showing 
M+H at m/z = 284.
The synthesis of 1 began with successful acetylation of stigmasterol 2 by acetic 
anhydride to form stigmasterol acetate 3 (Scheme 2). Although the yield (19%) was 
disappointing, the 1H-NMR spectrum closely matched the lit spectrum aside from the 
presence of ethyl acetate impurity. Epoxidation of 3 using m-CPBA resulted in a yield of 
104%, with water as the most likely impurity inflating the yield. Additionally, both α and β 
isomers were observed in the 1H NMR spectrum in a ratio of 0.67:0.33 in agreement with
the literature ratio (0.72:0.28).
The most recent synthesis step completed was the ozonolysis of compound 4. Due to 
safety concerns, we deviated from the literature procedure, which called for concentration in 
vacuo after O3 addition, followed by re-dissolution in H2O/AcOH and treatment with zinc. 
Rather, a work-up with triethylamine (2 equiv) was used. For O3 addition, we used an 
inexpensive multi-purpose ozone generator (rated at 1 g/h and purchased from Amazon) 
connected to an O2 tank. To test the capability of this O3 generator, a solution of 1-octene in 
1:1 DCM/MeOH was treated at -78 °C with a gaseous stream of ozone for 1.5 h, then 
successfully treated with triethylamine to give heptanal and formaldehyde as indicated by 
1H NMR. This procedure was then used for the attempted ozonolysis of 4. The product 
showed two aldehyde doublets (9.61, 9.52 ppm) with the same coupling constant (3.4 Hz) 
and the predicted 2:1 α/β ratio in the 1H NMR spectrum (Figure 3). In addition, the side 
chain double bond was fully reacted as indicated by the disappearance of the doublets of 
doublets at 5 ppm. Thus, the ozonolysis went to completion. Unfortunately, for reasons we 
have yet to determine, the integration values of the aldehyde doublets (0.26, 0.12) are small 
compared to the other peaks and there appear to be additional smaller aldehyde peaks. It is 
possible that the triethylamine work-up caused epimerization at the α-carbon of the 
aldehyde, something we were not anticipating, leading to the extra aldehyde peaks observed. 
Therefore, the next step of this research will be to look further into what is causing the small 
aldehyde peaks and repeating the ozonolysis with a different reductive work-up reagent, e.g. 
dimethylsulfide or zinc.. 
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Figure 3: 300 MHz 1H NMR of Pregnane-20α-carboxaldehyde-5,6-epoxy-3-yl acetate
Synthesis of the modified Julia reagent was successfully completed in three steps in which 
9, 10, and 11 were produced with good purity and decent yield (56%, 72%, 20%). 
The first two steps in the synthesis of 1, acetylation of stigmasterol then epoxidation using 
mCPBA, were accomplished with yields of 19% and 104%. Following epoxidation, both α 
and β isomers were observed in a ratio of 0.67:0.33.
Currently, we are looking further into the results of our ozonolysis reaction to determine 
why the aldehyde peaks are small compared to the other peaks. We may repeat the 
ozonolysis again with an alternative work-up.
After synthesizing 5 with good purity and yield, we will remove the epoxide using AlI3 
because of its potential to react with the nucleophilic Julia reagent (11). 
We anticipate that sequential Julia and Wittig reactions followed by hydrolysis of the acetate 
ester will afford 1.
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